JP2007530029A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007530029A5 JP2007530029A5 JP2007504561A JP2007504561A JP2007530029A5 JP 2007530029 A5 JP2007530029 A5 JP 2007530029A5 JP 2007504561 A JP2007504561 A JP 2007504561A JP 2007504561 A JP2007504561 A JP 2007504561A JP 2007530029 A5 JP2007530029 A5 JP 2007530029A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- seq
- sequence
- inhibitor
- injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55672404P | 2004-03-26 | 2004-03-26 | |
| PCT/IL2005/000342 WO2005091716A2 (en) | 2004-03-26 | 2005-03-27 | Annexin ii and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007530029A JP2007530029A (ja) | 2007-11-01 |
| JP2007530029A5 true JP2007530029A5 (https=) | 2008-05-08 |
Family
ID=35056607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007504561A Withdrawn JP2007530029A (ja) | 2004-03-26 | 2005-03-27 | アネキシンｉｉ及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20070098812A1 (https=) |
| EP (1) | EP1753464A2 (https=) |
| JP (1) | JP2007530029A (https=) |
| CA (1) | CA2560923A1 (https=) |
| WO (1) | WO2005091716A2 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7840270B2 (en) | 2003-07-23 | 2010-11-23 | Synapse Biomedical, Inc. | System and method for conditioning a diaphragm of a patient |
| JP2007530029A (ja) * | 2004-03-26 | 2007-11-01 | クアーク・ファーマスーティカルス、インコーポレイテッド | アネキシンｉｉ及びその使用 |
| US9050005B2 (en) | 2005-08-25 | 2015-06-09 | Synapse Biomedical, Inc. | Method and apparatus for transgastric neurostimulation |
| EP1996284A2 (en) * | 2006-03-09 | 2008-12-03 | Synapse Biomedical, Inc. | Ventilatory assist system and method to improve respiratory function |
| US20080097153A1 (en) * | 2006-08-24 | 2008-04-24 | Ignagni Anthony R | Method and apparatus for grasping an abdominal wall |
| US9079016B2 (en) * | 2007-02-05 | 2015-07-14 | Synapse Biomedical, Inc. | Removable intramuscular electrode |
| WO2008144578A1 (en) * | 2007-05-17 | 2008-11-27 | Synapse Biomedical, Inc. | Devices and methods for assessing motor point electromyogram as a biomarker |
| US8478412B2 (en) * | 2007-10-30 | 2013-07-02 | Synapse Biomedical, Inc. | Method of improving sleep disordered breathing |
| US8428726B2 (en) | 2007-10-30 | 2013-04-23 | Synapse Biomedical, Inc. | Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system |
| EP2143735A1 (en) * | 2008-07-10 | 2010-01-13 | Institut Pasteur | Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| US20100008900A1 (en) * | 2008-07-14 | 2010-01-14 | The University Of Hong Kong | Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| PL2503883T3 (pl) * | 2009-11-24 | 2016-09-30 | Kompozycja dezynfekująca | |
| JP6239635B2 (ja) | 2012-11-02 | 2017-11-29 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． | 血管石灰化の誘導因子であるソルチリン１ |
| WO2014071128A1 (en) * | 2012-11-02 | 2014-05-08 | The Brigham And Women's Hospital, Inc. | Macrophage-derived matrix vesicles: an alternative mechanism for microcalcification in atherosclerotic plaques |
| CA3043768A1 (en) | 2016-11-29 | 2018-06-07 | PureTech Health LLC | Exosomes for delivery of therapeutic agents |
| IT201900013758A1 (it) * | 2019-08-01 | 2021-02-01 | Biomimesi Srl | Membrana fosfolipidica attiva e relativo processo di produzione |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT384032B (de) * | 1985-01-14 | 1987-09-25 | Immuno Ag | Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag) |
| US5179001A (en) * | 1985-09-27 | 1993-01-12 | The Regents Of The University Of California | Detection and monitoring of chronic and gram-negative infection |
| AT391080B (de) * | 1986-06-24 | 1990-08-10 | Immuno Ag | Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen |
| US5237053A (en) * | 1986-06-24 | 1993-08-17 | Immuno Aktiengesellschaft | Preparation active against Pseudomonas aeruginosa infections and methods of producing them |
| US4834976A (en) * | 1986-07-03 | 1989-05-30 | Genetic Systems Corporation | Monoclonal antibodies to pseudomonas aeruginosa flagella |
| DK2224012T3 (da) * | 2001-12-17 | 2013-05-13 | Corixa Corp | Sammensætninger og fremgangsmåder til terapi og diagnose af inflammatoriske tarmsygdomme |
| CN101899114A (zh) * | 2002-12-23 | 2010-12-01 | 惠氏公司 | 抗pd-1抗体及其用途 |
| AU2004207010A1 (en) * | 2003-01-30 | 2004-08-12 | Dynogen Pharmaceuticals, Inc. | Methods of treating lower urinary tract disorders using sodium channel modulators |
| WO2004066987A2 (en) * | 2003-01-30 | 2004-08-12 | Dynogen Pharmaceuticals, Inc. | Use of sodium channel modulators for treating gastrointestinal tract disorders |
| US7973139B2 (en) * | 2004-03-26 | 2011-07-05 | Human Genome Sciences, Inc. | Antibodies against nogo receptor |
| JP2007530029A (ja) * | 2004-03-26 | 2007-11-01 | クアーク・ファーマスーティカルス、インコーポレイテッド | アネキシンｉｉ及びその使用 |
-
2005
- 2005-03-27 JP JP2007504561A patent/JP2007530029A/ja not_active Withdrawn
- 2005-03-27 CA CA002560923A patent/CA2560923A1/en not_active Abandoned
- 2005-03-27 EP EP05718915A patent/EP1753464A2/en not_active Withdrawn
- 2005-03-27 WO PCT/IL2005/000342 patent/WO2005091716A2/en not_active Ceased
-
2006
- 2006-09-26 US US11/528,237 patent/US20070098812A1/en not_active Abandoned
-
2008
- 2008-08-12 US US12/228,545 patent/US20090214575A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007530029A5 (https=) | ||
| US8236280B2 (en) | Polyamides for nucleic acid delivery | |
| JP2008525033A5 (https=) | ||
| EP2573185A3 (en) | Lentiviral vectors and their use | |
| JP2010519289A5 (https=) | ||
| JP2015518714A5 (https=) | ||
| JP2003533986A5 (https=) | ||
| JP2015519891A5 (https=) | ||
| JP2009102380A5 (ja) | ｄｓＲＮＡを含む、ウイルス感染又は望ましくない細胞増殖によって媒介されるか又は誘導される病気又は疾患の治療用組成物 | |
| JP2013525330A5 (https=) | ||
| JP2015502346A5 (https=) | ||
| JP2012513193A5 (https=) | ||
| JP2012505657A5 (https=) | ||
| JP2015522264A5 (https=) | ||
| JP2005517436A5 (https=) | ||
| TW201130495A (en) | Organic compositions to treat HSF1-related diseases | |
| JP2019534884A5 (https=) | ||
| JP2011505414A5 (https=) | ||
| WO2005076744A3 (en) | Method for the preparation of peptide-oligonucleotide conjugates | |
| JP2022518384A5 (https=) | ||
| JP2009534451A5 (https=) | ||
| JP2007528216A5 (https=) | ||
| JP2013537404A5 (https=) | ||
| JP6041373B2 (ja) | ＴＮＦ−αに結合するアプタマー分子 | |
| ES2322963T3 (es) | Material dental que contiene compuestos dendriticos. |